Vijayan, Aneesh
Cooper, Tamara
Kolfschoten, Marijn van der Neut
Heinemann, Gary
Van Kampen, Mirjam
Boedhoe, Satish
van Diepen, Harry
Serroyen, Jan
Hayball, John
Hobbs, Leanne
Collins, Anne
Custers, Jerome
Zahn, Roland
Vogels, Ronald
Article History
Received: 26 September 2025
Accepted: 18 May 2026
First Online: 23 May 2026
Competing interests
: The authors declare the following competing interests: A.V., M.N.K., M.V.K., S.B., H.V.D., J.S., R.Z., J.C., and R.V are or were employees of Janssen Vaccines & Prevention B.V. or of Johnson & Johnson Innovative Medicine while engaged in the research project. These authors held or still hold stock in Johnson & Johnson. A.C., L.H., and J.H. are current or past employees of Sementis Ltd. A.C., L.H., J.H., T.C., and G.H. own stock or hold stock options in Sementis Ltd. Research activities performed at the University of South Australia (UniSA) were conducted as a collaboration between UniSA and Sementis Ltd, with UniSA salaries and project support from funds provided by Sementis Ltd.